These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 27086392)

  • 41. Neonatal opioid withdrawal syndrome.
    Sutter MB; Leeman L; Hsi A
    Obstet Gynecol Clin North Am; 2014 Jun; 41(2):317-34. PubMed ID: 24845493
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Bupreorphine:a new pharmacotherapy for opioid addictions treatment.
    Stock C; Shum JH
    J Pain Palliat Care Pharmacother; 2004; 18(3):35-54. PubMed ID: 15364630
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Predictive factors for patient maintenance on buprenorphine high dosage treatment: a naturalistic study in primary care].
    Gasquet I; Lançon C; Parquet P
    Encephale; 1999; 25(6):645-51. PubMed ID: 10668610
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Buprenorphine: a newer drug for treating neonatal abstinence syndrome.
    Bell SG
    Neonatal Netw; 2012; 31(3):178-83. PubMed ID: 22564314
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Buprenorphine and naloxone interactions in methadone maintenance patients.
    Mendelson J; Jones RT; Welm S; Brown J; Batki SL
    Biol Psychiatry; 1997 Jun; 41(11):1095-101. PubMed ID: 9146820
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Buprenorphine and methadone for opioid addiction during pregnancy.
    Mozurkewich EL; Rayburn WF
    Obstet Gynecol Clin North Am; 2014 Jun; 41(2):241-53. PubMed ID: 24845488
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Potential of buprenorphine/naltrexone in treating polydrug addiction and co-occurring psychiatric disorders.
    McCann DJ
    Clin Pharmacol Ther; 2008 Apr; 83(4):627-30. PubMed ID: 18212797
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Maintenance for opioid addiction with buprenorphine and methadone: "The only thing new in the world is the history you don't know".
    Stimmel B
    J Addict Dis; 2005; 24(3):1-6. PubMed ID: 16186079
    [No Abstract]   [Full Text] [Related]  

  • 49. Buprenorphine in the treatment of opioid dependence.
    George S; Day E
    Br J Hosp Med (Lond); 2007 Nov; 68(11):594-7. PubMed ID: 18087846
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The diverse clinical uses of opioid receptor drugs.
    Howland RH
    J Psychosoc Nurs Ment Health Serv; 2010 May; 48(5):11-4. PubMed ID: 20415289
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Long-term course of opioid addiction.
    Hser YI; Evans E; Grella C; Ling W; Anglin D
    Harv Rev Psychiatry; 2015; 23(2):76-89. PubMed ID: 25747921
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Drugs approved for opiate dependence.
    FDA Consum; 2003; 37(1):6. PubMed ID: 12625293
    [No Abstract]   [Full Text] [Related]  

  • 53. Medications for addiction treatment: an opportunity for prescribing clinicians to facilitate remission from alcohol and opioid use disorders.
    Park TW; Friedmann PD
    R I Med J (2013); 2014 Oct; 97(10):20-4. PubMed ID: 25271655
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pathophysiology of drug dependence.
    Galynker II; Goldfarb CR; Ongseng F; Finestone H
    J Nucl Med; 1996 Dec; 37(12):2098. PubMed ID: 8970542
    [No Abstract]   [Full Text] [Related]  

  • 55. Research network involvement and addiction treatment center staff: counselor attitudes toward buprenorphine.
    Knudsen HK; Ducharme LJ; Roman PM
    Am J Addict; 2007; 16(5):365-71. PubMed ID: 17882607
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pharmacological treatments for substance use disorders.
    Bailey KP
    J Psychosoc Nurs Ment Health Serv; 2004 Aug; 42(8):14-20. PubMed ID: 15354595
    [No Abstract]   [Full Text] [Related]  

  • 57. Narcotic antagonists: new methods to treat heroin addiction.
    Hammond AL
    Science; 1971 Aug; 173(3996):503-6. PubMed ID: 5564039
    [No Abstract]   [Full Text] [Related]  

  • 58. Basic concepts and use of cyclazocine in the treatment of narcotic addiction.
    Freedman AM; Fink M
    Br J Addict Alcohol Other Drugs; 1968 Sep; 63(1):59-69. PubMed ID: 5245946
    [No Abstract]   [Full Text] [Related]  

  • 59. Treating drug-addiction.
    Fink M; Freedman AM
    Lancet; 1968 Jun; 1(7554):1256. PubMed ID: 4172818
    [No Abstract]   [Full Text] [Related]  

  • 60. Successful Transition from Fentanyl to Buprenorphine in a Community-based Withdrawal Management Setting.
    Hartley J; Rieke E; Blazes C; Smith B; Gregg J
    J Addict Med; 2023 Jan-Feb 01; 17(1):117-118. PubMed ID: 35861342
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.